Survival benefit of multimodal local therapy for repeat recurrence of thoracic esophageal squamous cell carcinoma after esophagectomy

被引:4
|
作者
Ninomiya, Itasu [1 ]
Okamoto, Koichi [1 ]
Fushida, Sachio [1 ]
Kinoshita, Jun [1 ]
Takamura, Hiroyuki [1 ]
Tajima, Hidehiro [1 ]
Makino, Isamu [1 ]
Miyashita, Tomoharu [1 ]
Ohta, Tetsuo [1 ]
机构
[1] Kanazawa Univ, Dept Gastroenterol Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
关键词
Esophageal neoplasm; Recurrence; Surgery; Intensity-modulated radiotherapy; LYMPH-NODE DISSECTION; INTENSITY-MODULATED RADIOTHERAPY; EXTENDED RADICAL ESOPHAGECTOMY; THORACOSCOPIC ESOPHAGECTOMY; CURATIVE RESECTION; RADIATION-THERAPY; CANCER; PATTERN;
D O I
10.1007/s10388-018-0638-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThis study was performed to clarify the optimal therapeutic strategy for recurrent disease after esophagectomy.MethodsWe investigated the prognosis of 37 patients who developed recurrence among 128 patients who underwent curative thoracoscopic esophagectomy (TE) at Kanazawa University Hospital. The prognostic factors after recurrence were examined by univariate and multivariate analyses.ResultsOf these 37 recurrences, 29 patients underwent local therapy (surgery, 10 patients; surgery followed by radiation, 2 patients; radiation, 17 patients). Radiation includes intensity-modulated radiation therapy, chemoradiation, and simple radiation therapy. Seventeen patients (58.6%) were considered to have undergone successful therapy by disappearance or diminishment of the targeted region without regrowth. Eleven of 17 patients (64.7%) showed repeat recurrence at another site. Multiple local therapy was performed for repeat recurrence or uncontrollable first therapy. Finally, 57 local therapies were performed. Using multimodal local therapy, 37 (64.9%) of 57 recurrences were successfully managed. The 12 patients treated by surgery as the initial therapy showed the most favorable survival. Seventeen patients who underwent successful initial therapy showed better survival than others. Multiple or miscellaneous organ metastasis, abdominal lymphatic recurrence and best supportive care at recurrence were statistically significant negative variables for survival after recurrence. Performance of surgery and successful therapy as the initial recurrence were statistically significant positive variables for survival after recurrence. Multivariate analysis showed that successful therapy at the initial recurrence was the only independent variable for survival after recurrence.ConclusionsMultimodal local therapy for repeat recurrence after TE contributes to the improvement of survival after recurrence.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 50 条
  • [21] Accurate location describe and management of lymph node recurrence after esophagectomy for thoracic esophageal squamous cell carcinoma: a retrospective cohort study
    Zhao, Qian
    Sun, Jinglong
    Zheng, Feng
    Fu, Chengrui
    Sun, Hongfu
    Liu, Chengxin
    Wang, Zhongtang
    Huang, Wei
    Wang, Ruozheng
    Li, Baosheng
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (06) : 3440 - 3449
  • [22] Prognostic Factors for Post-Recurrence Survival in Patients with Thoracic Esophageal Squamous Cell Carcinoma after Curative Resection
    Nakajima, Yasuaki
    Kawada, Kenro
    Tokairin, Yutaka
    Tomita, Makoto
    Miyake, Satoshi
    Kawano, Tatsuyuki
    DIGESTIVE SURGERY, 2016, 33 (02) : 136 - 145
  • [23] Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinoma
    Lin, Dong
    Ma, Longfei
    Ye, Ting
    Pan, Yunjian
    Shao, Longlong
    Song, Zuodong
    Jiang, Shujun
    Chen, Haiquan
    Xiang, Jiaqing
    JOURNAL OF THORACIC DISEASE, 2017, 9 (02) : 318 - 326
  • [25] ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy
    Deng, Wei
    Chen, Junqiang
    Xiao, Zefen
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S802 - S803
  • [26] ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy
    Wei Deng
    Junqiang Chen
    Zefen Xiao
    Annals of Surgical Oncology, 2019, 26 : 802 - 803
  • [27] Significance of Thoracic Duct Resection During Esophagectomy for Esophageal Squamous Cell Carcinoma
    Shingo Kanaji
    Annals of Surgical Oncology, 2023, 30 : 2582 - 2583
  • [28] Salvage lymphadenectomy for cervical lymph node recurrence after esophagectomy for squamous cell carcinoma of the thoracic esophagus
    Watanabe, M.
    Nishida, K.
    Kimura, Y.
    Miyazaki, M.
    Baba, H.
    DISEASES OF THE ESOPHAGUS, 2012, 25 (01) : 62 - 66
  • [29] Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus
    Osugi, H
    Takemura, M
    Higashino, M
    Takada, N
    Lee, S
    Ueno, M
    Tanaka, Y
    Fukuhara, K
    Hashimoto, Y
    Fujiwara, Y
    Kinoshita, H
    ONCOLOGY REPORTS, 2003, 10 (01) : 81 - 87
  • [30] Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus
    Kanda, Mitsuro
    Koike, Masahiko
    Shimizu, Dai
    Tanaka, Chie
    Hattori, Norifumi
    Hayashi, Masamichi
    Yamada, Suguru
    Omae, Kenji
    Kodera, Yasuhiro
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (09) : 3195 - 3205